89 related articles for article (PubMed ID: 15788696)
21. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
Benjamin R; Helman L; Meyers P; Reaman G
Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
[TBL] [Abstract][Full Text] [Related]
22. Suppression of tumor growth and pulmonary metastasis in murine osteosarcoma using gene therapy.
Seto M; Yamazaki T; Sonoda J; Matsumine A; Shinto Y; Uchida A
Oncol Rep; 2002; 9(2):337-40. PubMed ID: 11836603
[TBL] [Abstract][Full Text] [Related]
23. Efficient repetitive gene delivery to skeletal muscle using recombinant adenovirus vector containing the Coxsackievirus and adenovirus receptor cDNA.
Kimura E; Maeda Y; Arima T; Nishida Y; Yamashita S; Hara A; Uyama E; Mita S; Uchino M
Gene Ther; 2001 Jan; 8(1):20-7. PubMed ID: 11402298
[TBL] [Abstract][Full Text] [Related]
24. Coxsackievirus and adenovirus receptor (CAR)-positive immature osteoblasts as targets of adenovirus-mediated gene transfer for fracture healing.
Ito T; Tokunaga K; Maruyama H; Kawashima H; Kitahara H; Horikoshi T; Ogose A; Hotta Y; Kuwano R; Katagiri H; Endo N
Gene Ther; 2003 Sep; 10(18):1623-8. PubMed ID: 12907955
[TBL] [Abstract][Full Text] [Related]
25. Hematoporphyrin monomethyl ether enhances the killing of ultrasound on osteosarcoma cells involving intracellular reactive oxygen species and calcium ion elevation.
Tian Z; Quan X; Leung AW; Xiang J; Xu C
Integr Cancer Ther; 2010 Dec; 9(4):365-9. PubMed ID: 20702491
[TBL] [Abstract][Full Text] [Related]
26. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated in vivo B7-1 gene transfer induces anti-tumor immunity against pre-established primary tumor and pulmonary metastasis of rat osteosarcoma.
Tsuji H; Kawaguchi S; Wada T; Nagoya S; Inobe M; Yamashita T; Ishii S; Uede T
Cancer Gene Ther; 2002 Sep; 9(9):747-55. PubMed ID: 12189524
[TBL] [Abstract][Full Text] [Related]
28. Highly variable expression of virus receptors in the human cardiovascular system. Implications for cardiotropic viral infections and gene therapy.
Poller W; Fechner H; Noutsias M; Tschoepe C; Schultheiss HP
Z Kardiol; 2002 Dec; 91(12):978-91. PubMed ID: 12490988
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral-mediated gene transfer of ectodysplasin-A2 results in induction of apoptosis and cell-cycle arrest in osteosarcoma cell lines.
Chang B; Punj V; Shindo M; Chaudhary PM
Cancer Gene Ther; 2007 Nov; 14(11):927-33. PubMed ID: 17693991
[TBL] [Abstract][Full Text] [Related]
30. Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.
Duan X; Jia SF; Koshkina N; Kleinerman ES
Cancer; 2006 Mar; 106(6):1382-8. PubMed ID: 16453328
[TBL] [Abstract][Full Text] [Related]
31. Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule.
Hemminki A; Dmitriev I; Liu B; Desmond RA; Alemany R; Curiel DT
Cancer Res; 2001 Sep; 61(17):6377-81. PubMed ID: 11522629
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of P-glycoprotein in high-grade osteosarcoma.
Serra M; Picci P; Ferrari S; Bacci G
J Clin Oncol; 2007 Oct; 25(30):4858-60; author reply 4860-1. PubMed ID: 17947741
[No Abstract] [Full Text] [Related]
33. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
Haydon RC; Luu HH; He TC
Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma.
Worth LL; Jaffe N; Benjamin RS; Papadopoulos NE; Patel S; Raymond AK; Jia SF; Rodriguez C; Gano J; Gianan MA; Kleinerman ES
Clin Cancer Res; 1997 Oct; 3(10):1721-9. PubMed ID: 9815556
[TBL] [Abstract][Full Text] [Related]
35. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma.
Sulzbacher I; Birner P; Trieb K; Träxler M; Lang S; Chott A
Mod Pathol; 2003 Jan; 16(1):66-71. PubMed ID: 12527715
[TBL] [Abstract][Full Text] [Related]
36. Ectopic expression of the coxsackievirus and adenovirus receptor increases susceptibility to adenoviral infection in the human cervical cancer cell line, SiHa.
Kim JS; Lee SH; Cho YS; Kim YH; Lee JH
Biochem Biophys Res Commun; 2001 Oct; 288(1):240-4. PubMed ID: 11594779
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
38. Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells.
Le LP; Rivera AA; Glasgow JN; Ternovoi VV; Wu H; Wang M; Smith BF; Siegal GP; Curiel DT
Gene Ther; 2006 Mar; 13(5):389-99. PubMed ID: 16292351
[TBL] [Abstract][Full Text] [Related]
39. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma.
Lamoureux F; Picarda G; Garrigue-Antar L; Baud'huin M; Trichet V; Vidal A; Miot-Noirault E; Pitard B; Heymann D; Rédini F
Cancer Res; 2009 Jan; 69(2):526-36. PubMed ID: 19147566
[TBL] [Abstract][Full Text] [Related]
40. Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy.
Rauen KA; Sudilovsky D; Le JL; Chew KL; Hann B; Weinberg V; Schmitt LD; McCormick F
Cancer Res; 2002 Jul; 62(13):3812-8. PubMed ID: 12097294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
